VAX2: A Potential Drug Target and Biomarker for Central Nervous System Disorders

Target Name: VAX2

NCBI ID: G25806

VAX2

Other Name(s): ventral anterior homeobox 2 | DRES93 | OTTHUMP00000160128 | Ventral anterior homeobox 2 | VAX2_HUMAN

VAX2: A Potential Drug Target and Biomarker for Central Nervous System Disorders

Introduction

The central nervous system (CNS) is a complex and dynamic system that plays a crucial role in the regulation of various physiological processes in the body. One of the key structures responsible for this regulation is the homeobox gene family, which encodes the molecules that define the spatial and temporal organization of the nervous system. The homeobox genes are involved in the development and maintenance of neural tissue structure, cell-cell interactions, growth and regeneration. VAX2 is a member of the homeobox gene family and has been identified as a potential drug target and biomarker for central nervous system (CNS) disorders.

History of the Homeobox Genes

The homeobox gene family is named after the protein homeobox, which is a transmembrane protein that plays a central role in the regulation of neural development and function. The first homeobox gene was identified in 1996, and since then, numerous additional genes have been identified in the homeobox gene family. These genes are involved in the development and maintenance of neural structures and are implicated in a wide range of CNS disorders, including neurological and psychiatric diseases.

VAX2: A putative drug target

VAX2 is a member of the homeobox gene family and has been shown to play a role in the development and maintenance of the nervous system. Studies have suggested that VAX2 may be involved in the regulation of neuronal stem cell proliferation and differentiation, as well as the regulation of neural circuit formation and plasticity. In addition, VAX2 has been shown to play a role in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

VAX2 has also been shown to interact with several other genes, including Notch1, which is a gene that is involved in the regulation of neural stem cell proliferation and differentiation. The interaction between VAX2 and Notch1 has been shown to play a role in the regulation of neuronal stem cell proliferation and the development of neural tissue structure.

VAX2 as a biomarker

The regulation of neural development and function is a complex process that is influenced by multiple factors, including genetic and environmental factors. In addition to its role in the regulation of neural stem cell proliferation and differentiation, VAX2 has also been shown to play a role in the regulation of neural circuit formation and plasticity. This suggests that VAX2 may be a useful biomarker for the diagnosis and treatment of central nervous system disorders.

VAX2 has been shown to be expressed in the brains of individuals with a variety of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In addition, studies have suggested that VAX2 may be involved in the regulation of neurodegenerate disease progression, as well as the development of neuroprotective agents. The potential use of VAX2 as a biomarker for the diagnosis and treatment of central nervous system disorders makes it an attractive target for further research.

Conclusion

VAX2 is a member of the homeobox gene family and has been shown to play a role in the development and maintenance of the nervous system. Its potential as a drug target and biomarker for central nervous system disorders makes it an attractive target for further research. Further studies are needed to fully understand the role of VAX2 in the regulation of neural development and function, as well as its potential as a biomarker for the diagnosis and treatment of central nervous system disorders.

Protein Name: Ventral Anterior Homeobox 2

Functions: Transcription factor that may function in dorsoventral specification of the forebrain. Regulates the expression of Wnt signaling antagonists including the expression of a truncated TCF7L2 isoform that cannot bind CTNNB1 and acts therefore as a potent dominant-negative Wnt antagonist. Plays a crucial role in eye development and, in particular, in the specification of the ventral optic vesicle (By similarity). May be a regulator of axial polarization in the retina

The "VAX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VAX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets